Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AMS
Upturn stock ratingUpturn stock rating

American Shared Hospital Service (AMS)

Upturn stock ratingUpturn stock rating
$2.33
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/20/2025: AMS (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -24.54%
Avg. Invested days 29
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/20/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 15.00M USD
Price to earnings Ratio 11.07
1Y Target Price 4.85
Price to earnings Ratio 11.07
1Y Target Price 4.85
Volume (30-day avg) 13825
Beta 0.29
52 Weeks Range 2.32 - 4.60
Updated Date 06/21/2025
52 Weeks Range 2.32 - 4.60
Updated Date 06/21/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.21

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 4.93%
Operating Margin (TTM) -14.17%

Management Effectiveness

Return on Assets (TTM) 0.71%
Return on Equity (TTM) 2%

Valuation

Trailing PE 11.07
Forward PE 7.58
Enterprise Value 31795250
Price to Sales(TTM) 0.51
Enterprise Value 31795250
Price to Sales(TTM) 0.51
Enterprise Value to Revenue 1.09
Enterprise Value to EBITDA 4.05
Shares Outstanding 6450000
Shares Floating 3419790
Shares Outstanding 6450000
Shares Floating 3419790
Percent Insiders 49.7
Percent Institutions 13.91

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

American Shared Hospital Service

stock logo

Company Overview

overview logo History and Background

American Shared Hospital Services (AMS:NYSE) was founded in 1980. Initially focused on providing shared services for medical equipment, it has evolved into a provider of Gamma Knife radiosurgery and proton therapy solutions.

business area logo Core Business Areas

  • Gamma Knife: Leasing, service, and installation of Leksell Gamma Knife Perfexion systems for non-invasive neurosurgery.
  • Proton Therapy: Development, financing, and operation of proton therapy centers.

leadership logo Leadership and Structure

Ernest A. Bates, M.D., is the Chairman and CEO. The company has a standard corporate structure with a board of directors and various management teams overseeing finance, operations, and business development.

Top Products and Market Share

overview logo Key Offerings

  • Gamma Knife Perfexion: The Leksell Gamma Knife Perfexion is a device used for stereotactic radiosurgery. American Shared leases these machines to hospitals. Competitors include Accuray (CyberKnife), Varian Medical Systems (Linacs). Market share data is limited, but AMS is a key player in this niche market.
  • Proton Therapy Systems: American Shared finances the development and operation of proton therapy centers, using machines from manufacturers such as IBA and Varian. Competitors include ProTom International, Hitachi. This is a growing market, but market share information is difficult to obtain.

Market Dynamics

industry overview logo Industry Overview

The market includes stereotactic radiosurgery and radiation therapy. Demand is growing due to aging population and advancements in technology. Healthcare regulations and insurance reimbursements play a significant role.

Positioning

American Shared focuses on providing access to advanced medical technologies to hospitals through leasing and shared service arrangements, acting as a facilitator for Gamma Knife and Proton Therapy solutions. The company doesn't manufacture this equipment, but provides access to it.

Total Addressable Market (TAM)

The TAM for radiation therapy and stereotactic radiosurgery is estimated to be in the billions of dollars annually. American Shared's position depends on its ability to secure contracts and build/manage facilities and Gamma Knife systems.

Upturn SWOT Analysis

Strengths

  • Established relationships with hospitals
  • Expertise in Gamma Knife and proton therapy
  • Recurring revenue from leasing agreements
  • Strong knowledge of medical technology finance.

Weaknesses

  • High dependence on a few key customers
  • Capital intensive business model
  • Sensitivity to changes in healthcare reimbursement policies
  • Smaller size compared to competitors

Opportunities

  • Expanding proton therapy market
  • Technological advancements in radiosurgery
  • Strategic partnerships with equipment manufacturers
  • Increased adoption of non-invasive treatment options

Threats

  • Competition from larger medical equipment companies
  • Changes in healthcare regulations
  • Economic downturns affecting hospital budgets
  • Technological obsolescence of existing equipment

Competitors and Market Share

competitor logo Key Competitors

  • VAR
  • Accuray (ARAY)
  • IBA (no US Stock symbol)

Competitive Landscape

American Shared benefits from its specialization, but larger companies have greater resources and broader product portfolios.

Major Acquisitions

Growth Trajectory and Initiatives

Historical Growth: Growth has been moderate, driven by expansion of proton therapy and Gamma Knife installations.

Future Projections: Analyst estimates for future growth vary. Need to get more info from reports.

Recent Initiatives: Recent initiatives include securing contracts for new proton therapy centers and Gamma Knife installations.

Summary

American Shared Hospital Services occupies a niche in providing Gamma Knife and proton therapy solutions, with recurring revenue from equipment leases. It faces challenges like capital intensity and competition from larger firms, but has growth opportunities with proton therapy expansion. Securing new contracts and maintaining existing hospital relationships are key for its future. Changes in healthcare reimbursement pose a risk.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company website
  • SEC filings
  • Industry reports
  • Analyst estimates

Disclaimers:

This analysis is based on available information and is not financial advice. Market share data is estimated. Financial data is not provided in this document due to lack of live real-time data.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About American Shared Hospital Service

Exchange NYSE MKT
Headquaters San Francisco, CA, United States
IPO Launch date 1984-09-07
CEO -
Sector Healthcare
Industry Medical Care Facilities
Full time employees 81
Full time employees 81

American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments, Leasing and Retail. The company leases nine Gamma Knife systems and one proton beam radiation therapy (PBRT) system; and provides planning, installation, reimbursement, and marketing support services. It also owns and operates two single-unit Gamma Knife facilities that provides radiosurgery services directly to the patient. The company markets its solutions to cancer treatment centers, health systems, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.